Clinical Neuromuscular Pathology Certification Examination Committee Contributors
P. James B. Dyck, MD, FAAN, Chair, Mayo Clinic – Rochester
Disclosures: Receives fees from Akcea pharmaceutical for speaking about TTR amyloid neuropathy.
Andrea M. Corse, MD, Vice Chair, Johns Hopkins Hospital
Disclosures: Received research funding from Biogen to present A Phase I, Multiple-Ascending-Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB078 Administered Intrathecally to Adults with C9ORF72-Associated Amyotrophic Lateral Sclerosis.
Robert C. Bucelli, MD, PhD, Washington University School of Medicine
Disclosures: Receives research support from Biogen for multiple ALS ASO trials at Washington University. Role: Principal investigator.
Mazen Mohammad Dimachkie, MD, University of Kansas Medical Center
Disclosures: Serves as a paid consultant for ArgenX, Catalyst, CSL-Behring, Kezar, Momenta, NuFactor, RMS Medical, Sanofi Genzyme, Shire Takeda, and Spark Therapeutics; received research grants from Alexion, Alnylam Pharmaceuticals, Amicus, Biomarin, Bristol-Myers Squibb, Catalyst, CSL-Behring, FDA/OOPD, GlaxoSmithKline, Genentech, Grifols, Mitsubishi Tanabe Pharma, MDA, NIH, Novartis, Sanofi Genzyme, Octapharma, Orphazyme, Sarepta Therapeutics, Shire Takeda, Spark, UCB Biopharma, Viromed & TMA.
Ahmed Mohamed Attia El-Dokla, MD, Neuromuscular Clinic at Upstate Bone & Joint
Disclosures: Nothing to disclose.
Shalini Mahajan, MD, Cedars-Sinai Medical Center
Disclosures: Nothing to disclose.
Raghav Govindarajan, MD, University of Missouri
Disclosures: Received compensation from Alexion MT PHARMA Catalyst PHARMA Argenx Infucare; received publication fees from Springer Publishing; research support received from Ra PHARMA Alexion Dysimmune foundation Band of Hope foundation.
Margherita Milone, MD, PhD, Mayo Clinic – Rochester
Disclosures: Receives compensation for serving as associate editor of Neurology Genetics; Receives research funding by Mayo Clinic benefactor.
Michelle Lynn Mauermann, MD, Mayo Clinic – Rochester
Disclosures: Receives research support from Alnylam for TTR amyloid clinical trial and from IONIS for TTR amyloid clinical trial.
Aziz Shaibani, MD, Nerve and Muscle Center of Texas
Disclosures: Received compensation to serve on Stealth BioTherapeutics advisory board regarding primary mitochondrial myopathy (PMM) and elamipretide.